Prompt Diagnostics, Inc.
Baltimore, MD
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
- SAM.gov registration date
- Physical address
- 2401 W Belvedere Ave #313, Baltimore, MD 21215, USA
- Website
- prompt-dx.com
- Employees
- 1-10
- Estimated annual revenue
- $0-$1M
- Industry
-
- Health Care
- Health Care Equipment & Services
- Health Care Providers & Services
- Health Care Services
- SIC code
- 80 Health Services
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $0 |
| FY2025 | $300,000 |
Contract awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Prompt point-of-care HIV viral load monitoring | National Institute of Allergy and Infectious Diseases (NIH) | $300,000 | |
| Rapid detection device for C auris | CDC Pittsburgh | $243,179 |
Contract subawards
| Prime contractor | Prime award | Amount | Awarded |
|---|---|---|---|
| Trustees Of Boston University | 75A50122C00028 | $299,993 |
Grant awards
Grant subawards
| Prime recipient | Prime award | Amount | Awarded |
|---|---|---|---|
| Emory University | U54EB027690 | $16,963 | |
| The Johns Hopkins University | U54EB007958 | $149,996 | |
| Northwestern University | U54EB027049 | $249,987 |
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Gate Scientific, Inc. | Milpitas, CA | 334516 Analytical Laboratory Instrument Manufacturing |
| Lo Biosciences, Inc. | North Bethesda, MD | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| Salus Discovery LLC | Monona, WI | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| Instadiagnostics Inc. | Philadelphia, PA | 339112 Surgical and Medical Instrument Manufacturing |
| Big Eye Diagnostics Inc. | San Diego, CA | 325413 In-Vitro Diagnostic Substance Manufacturing |
About the company
Prompt Diagnostics, Inc. is a for-profit corporate entity specializing in advanced diagnostic technologies, with a primary focus on developing innovative point-of-care diagnostic platforms for infectious diseases. Registered in SAM.gov since December 2020, the company is a manufacturer of goods that has demonstrated significant capability in creating rapid, multiplexed diagnostic solutions for various medical conditions. The company's core competency lies in developing portable, rapid testing technologies that can detect and characterize infectious diseases, with a particular emphasis on sexually transmitted infections, HIV, and emerging pathogens.
Through federal contract awards, Prompt Diagnostics has secured contracts with agencies like the Centers for Disease Control and Prevention (CDC), specifically delivering a rapid detection device for Candida auris with a contract value of $243,179. The company has been awarded Small Business Innovation Research (SBIR) contracts, including a $300,000 firm-fixed-price contract from the National Institute of Allergy and Infectious Diseases (NIAID) to develop a point-of-care HIV viral load monitoring system. These contracts have been predominantly set aside for small businesses and focus on developing advanced diagnostic technologies that can provide quick, accurate pathogen detection in decentralized settings.
On the grant side, Prompt Diagnostics has received significant funding from the National Science Foundation (NSF) and NIAID to develop sophisticated diagnostic platforms. Notable grant projects include a $1,250,000 cooperative agreement to create an automated diagnostic test for syphilis, a Phase I SBIR grant for developing a hybrid DNA-protein quantification platform for point-of-care diagnosis of syphilis and HIV, and a grant for a portable magnetofluidic platform for rapid multiplexed detection of sexually transmitted infections. The company has also engaged in sub-grant collaborations with prestigious institutions like Johns Hopkins University and Northwestern University, specifically working on centers for innovative diagnostics and point-of-care technologies for infectious diseases. These grants consistently demonstrate the company's commitment to developing rapid, affordable, and comprehensive diagnostic solutions that can be deployed in resource-limited settings.
Quick answers
Is Prompt Diagnostics, Inc. registered in SAM.gov?
Yes. Prompt Diagnostics, Inc.'s SAM.gov registration is active through January 23, 2027.
What is Prompt Diagnostics, Inc.'s CAGE code?
Prompt Diagnostics, Inc.'s CAGE code is 8TGK1, and its Unique Entity ID (UEI) is L28FVGJ715D7.
How much has Prompt Diagnostics, Inc. received in federal contracts?
Federal contracts obligated $300,000 to Prompt Diagnostics, Inc. in fiscal year 2025.
What is Prompt Diagnostics, Inc.'s most recent federal award?
Prompt Diagnostics, Inc.'s most recent federal contract award is Prompt point-of-care HIV viral load monitoring (75N93025C00030), from National Institute of Allergy and Infectious Diseases (NIH), on September 1, 2025.
On GovTribe
See Prompt Diagnostics, Inc.'s full federal record
- Federal contract awards
- Federal grant awards
- Subcontracting relationships
- Funding analysis by agency, NAICS and set-aside
- Similar vendors